Publications

Link to publications on PubMed here.

Link to Google Scholar profile here.

Link to thesis (2010) “Innate Mechanisms Regulating Peripheral B cell Tolerance” here.

Link to patent “Anti-inflammatory agents” here.

Link to popular scientific texts here

 

Original articles 

1. Panda SK, Wigerblad G, Jiang L, Jiménez-Andrade Y, Iyer VS, Shen Y, Boddul SV, Guerreiro-Cacais AO, Raposo B, Kasza Z, WERMELING F.

IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints.

Proc Natl Acad Sci U S A. online 20 January 2020. doi: 10.1073/pnas.1914186117. link, PDF

Press release: https://news.ki.se/proteins-that-protect-against-joint-inflammation-identified

 

2. Xu X, Makaraviciute A, Abdurakhmanov E, WERMELING F, Li S, Danielson HU, Nyholm L, Zhang Z

Estimating Detection Limits of Potentiometric DNA Sensors Using Surface Plasmon Resonance Analyses.

ACS Sens, 2020 Jan 24;5(1), 217-224. Doi: 10.1021/acssensors.9b02086. link

 

3. Schulz A, Jiang L, de Vor L, Ehrström M, WERMELING F, Eidsmo L, Melican K.

Neutrophil Recruitment to Noninvasive MRSA at the Stratum Corneum of Human Skin Mediates Transient Colonization.

Cell Rep. 2019 Oct 29;29(5):1074-1081.e5. doi: 10.1016/j.celrep.2019.09.055. link

 

4. Record J, Sendel A, Kritikou JS, Kuznetsov NV, Brauner H, He M, Nagy N, Oliveira MMS, Griseti E, Haase CB, Dahlström J, Boddul S, WERMELING F, Thrasher AJ, Liu C, Andersson J, Claesson HE, Winqvist O, Burns SO, Björkholm M, Westerberg LS.

An intronic deletion in megakaryoblastic leukemia 1 is associated with hyperproliferation of B cells in triplets with Hodgkin lymphoma.

Haematologica. 2019 Oct 3. pii: haematol.2019.216317. doi: 10.3324/haematol.2019.216317. link

 

5. Bersellini Farinotti A, Wigerblad G, Nascimento D, Bas DB, Morado Urbina C, Nandakumar KS, Sandor K, Xu B, Abdelmoaty S, Hunt MA, Ängeby Möller K, Baharpoor A, Sinclair J, Jardemark K, Lanner JT, Khmaladze I, Borm LE, Zhang L, WERMELING F, Cragg MS, Lengqvist J, Chabot-Doré AJ, Diatchenko L, Belfer I, Collin M, Kultima K, Heyman B, Jimenez-Andrade JM, Codeluppi S, Holmdahl R, Svensson CI.

Cartilage-binding antibodies induce pain through immune complex-mediated activation of neurons.

J Exp Med. 2019 Aug 5;216(8):1904-1924. doi: 10.1084/jem.20181657. link

 

6. Centa M, Jin H, Hofste L, Hellberg S, Busch A, Baumgartner R, Verzaal NJ, Lind Enoksson S, Perisic Matic L, Boddul SV, Atzler D, Li DY, Sun C, Hansson GK, Ketelhuth DFJ, Hedin U, WERMELING F, Lutgens E, Binder CJ, Maegdesfessel L, Malin SG.

Germinal Center-Derived Antibodies Promote Atherosclerosis Plaque Size and Stability.

Circulation. 2019 May 21;139(21):2466-2482. doi: 10.1161/CIRCULATIONAHA.118.038534. link

 

7. Lloyd KA, Wigerblad G, Sahlstrom, P, Garimella MG, Chemin K, Steen J, Titcombe PJ, Marklein B, Zhou DN, Stalesen R, Ossipova E, Lundqvist C, Ekwall O, Ronnelid J, Mueller DL, Karlsson MCI, Kaplan MJ, Skriner K, Klareskog L, WERMELING F, Malmstrom V, Gronwall C.

Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis

Front Immunol. 2019 Jan 4;9:3033. DOI: 10.3389/fimmu.2018.03033. link

 

8. Parodis I, Söder F, Faustini F, Kasza Z, Samuelsson I, Zickert A, Svenungsson E, van Vollenhoven RF, Malmström V, WERMELING F, Gunnarsson I.

Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus – distinct roles of BAFF and APRIL.

Lupus. 2018 Aug;27(9):1470-1478. doi: 10.1177/0961203318777116. link

 

9. Habir K, Aeinehband S, WERMELING F, Malin S.

A Role for the Transcription Factor Arid3a in Mouse B2 Lymphocyte Expansion and Peritoneal B1a Generation.

Front Immunol. 2017 Oct 24;8:1387. doi: 10.3389/fimmu.2017.01387. link

 

10. Panda, SK, Boddul S, Jiménez-Andrade G, Jiang L, Kasza Z, Fernandez-Ricaud L and WERMELING F.

Green Listed – A CRISPR Screen Tool.

Bioinformatics. 2017 Apr 1;33(7):1099-1100. doi: 10.1093/bioinformatics/btw739. link, PDF

Press release: https://news.ki.se/new-software-makes-crispr-methodology-easier

 

11. Duhlin A, Chen Y, WERMELING F, Sedimbi SK, Lindh E, Shinde R, Halaby MJ, Kaiser Y, Winqvist O, McGaha TL, Karlsson MC.

Selective Memory to Apoptotic Cell-Derived Self-Antigens with Implications for Systemic Lupus Erythematosus Development.

J Immunol. 2016 Oct 1;197(7):2618-26. doi: 10.4049/jimmunol.1401129. link

 

12. Kritikou JS, Dahlberg C, Baptista MA, Wagner AK, Banerjee PP, Gwalani LA, Poli C, Panda SK, Kärre K, Kaech SM, WERMELING F, Andersson J, Orange JS, Brauner H, Westerberg LS.

IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo.

Sci Rep. 2016 Aug 1;6:30636. doi: 10.1038/srep30636.link

13. Prokopec KE, Georgoudaki AM, Sohn S, WERMELING F, Grönlund H, Lindh E, Carroll MC, Karlsson MC.

Cutting Edge: Marginal Zone Macrophages Regulate Antigen Transport by B Cells to the Follicle in the Spleen via CD21.

J Immunol. 2016 Sep 15;197(6):2063-8. doi: 10.4049/jimmunol.1502282.  link

 

14. Bosma M, Gerling M, Pasto J, Georgiadi A, Graham E, Shilkova O, Iwata Y, Almer S, Söderman J, Toftgård R, WERMELING F, Boström EA, Boström PA.

FNDC4 acts as an anti-inflammatory factor on macrophages and improves colitis in mice.

Nat Commun. 2016 Apr 12;7:11314. doi: 10.1038/ncomms11314. link

 

15. Siegmann N, Worbs D, Effinger F, Bormann T, Gebhardt M, Ulrich M, WERMELING F, Müller-Hermelink E, Biedermann T, Tighe M, Edwards MJ, Caldwell C, Leadbetter E, Karlsson MCI, Becker KA, Gulbins E, and Döring G.

Invariant natural killer T (iNKT) cells prevent autoimmunity, but induce pulmonary inflammation in cystic fibrosis.

Cell Physiol Biochem. 2014;34(1):56-70. doi: 10.1159/000362984. link

 

16. WERMELING F, Anthony RM, Brombacher F, and Ravetch JV.

Acute inflammation primes myeloid effector cells for anti-inflammatory STAT6 signaling.

Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13487-91. doi: 10.1073/pnas.1312525110. link, PDF

 

17. Lindh E, Brännström J, Jones P, WERMELING F, Hässler S, Betterle C, Garty BZ, Stridsberg M, Herrmann B, Karlsson MCI, Winqvist O.

Autoimmunity and cystatin SA 1 deficiency behind chronic mucocutaneous candidiasis in autoimmune polyendocrine syndrome type 1.

J Autoimmun. 2013 May;42:1-6. doi: 10.1016/j.jaut.2012.10.001. link

 

18. Anthony RM, Kobayashi T, WERMELING F and Ravetch JV.

Intravenous gammaglobulin suppresses inflammation through a Novel TH2 Pathway.

Nature. 2011 Jun 19;475(7354):110-3. doi: 10.1038/nature10134. link

 

19. Sakthivel P, WERMELING F, Elmgren A, Hulthe J, Kakoulidou M, Lefvert AK and Lind L.

Circulating soluble CTLA-4 is related to inflammatory markers in the 70 year old population.

Scand J Clin Lab Invest. 2010 Jul;70(4):237-43. doi: 10.3109/00365511003695608. link

 

20. WERMELING F, Lind S. M, Domange Jordö E., Cardell S, and Karlsson MCI.

Invariant NKT cells limit activation of autoreactive CD1d positive B cells.

J Exp Med. 2010 May 10;207(5):943-52. doi: 10.1084/jem.20091314. linkPDF

[Highlighted in Nat Rev Immunol. 2010 Jun;10(6):384 link]

 

21. Chen Y, WERMELING F, Sundqvist J, Jonsson AB, Tryggvason K, Pikkarainen T and Karlsson MCI.

A regulatory role for macrophage class A scavenger receptors in TLR4-mediated LPS responses.

Eur J Immunol. 2010 May;40(5):1451-60. doi: 10.1002/eji.200939891. link

 

22. Thunberg S, Neimert-Andersson T, Cheng Q, WERMELING F, Bergström U, Swedin L, Dahlén SE, Arnér E, Scheynius A, Karlsson MC, Gafvelin G, van Hage M, Grönlund H.

Prolonged antigen-exposure with carbohydrate particle based vaccination prevents allergic immune responses in sensitized mice.

Allergy. 2009 Jun;64(6):919-26. link

 

23. Anthony RM, WERMELING F, Karlsson MC, Ravetch JV.

Identification of a receptor required for the anti-inflammatory activity of IVIG.

Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19571-8.  link

 

24. Westerberg LS, de la Fuente MA, WERMELING F, Ochs HD, Karlsson MC, Snapper SB, Notarangelo LD.

WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function.

Blood. 2008 Nov 15;112(10):4139-47 link

 

25. WERMELING F, Chen Y, Pikkarainen T, Scheynius A, Winqvist O, Izui S, Ravetch JV, Tryggvason K, Karlsson MC.

Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus.

J Exp Med. 2007 Oct 1;204(10):2259-65. linkPDF

[Highlighted in Nat Clin Pract Rheumatology, 2008, 4:7]

——-

Reviews:

1. Iyer VS, Jiang J, Shen Y, Boddul SV, Panda SK, Kasza Z, Schmierer B, WERMELING F

Designing custom CRISPR libraries for hypothesis-driven drug target discovery

Comput Struct Biotechnol J August 2020.  doi: 10.1016/j.csbj.2020.08.009 link

 

2. Anthony RM, WERMELING F and Ravetch JV.

Novel roles of the IgG Fc glycan.

Ann N Y Acad Sci. 2012 Apr;1253:170-80. doi: 10.1111/j.1749-6632.2011.06305.x. link

 

3. Jordö ED, WERMELING F, Chen Y and Karlsson MCI.

Scavenger receptors as regulators of natural antibody responses and B cell activation in autoimmunity.

Mol Immunol. 2011 Jun;48(11):1307-18. doi: 10.1016/j.molimm.2011.01.010. link

 

4. WERMELING F, Karlsson MC, McGaha TL.

An anatomical view on macrophages in tolerance.

Autoimmun Rev. 2009 Sep;9(1):49-52. link

 

——-